This ticker has not been starred yet CTSO Cytosorbents Corp
Surgical & Medical Instruments & Apparatus
Book value per $ invested $ 0.33
Leverage 80.28%
Market Cap $ 27.6m
PE 0.00
Dividend Yield 0.00%
Profit $ -10.5m
Margin -29.06%

Cytosorbents Corporation, a critical care focused immunotherapy company, is dedicated to the research, development and commercialization of medical devices with its blood purification technology platform incorporating proprietary adsorbent and porous polymer technology. The company is headquartered in Monmouth Junction, New Jersey.

Subscribe Now For Access - Only $1.99 Per Month